Tuesday, May 26, 2026
ADVT 
International

US issues record-high 1.4 mn visas to Indians in 2023

Darpan News Desk IANS, 29 Jan, 2024 01:57 PM
  • US issues record-high 1.4 mn visas to Indians in 2023

New Delhi, Jan 29 (IANS) Bringing down the visitor visa appointment wait times by 75 per cent, the US Consular Team in India processed a record-smashing 1.4 million US visas in the year 2023.

Stating that the demand across all visa classes was unprecedented -- with a 60 per cent increase in applications compared to 2022 -- the US Embassy and Consulates said on Monday that Indians now represent one out of every 10 US visa applicants around the world.

In addition, visitor visas (B1/B2) rebounded to represent the second-highest number of applications in the US Mission’s history -- over 700,000.

The US Embassy and Consulates said that it met this demand through a three-month staffing surge in Mumbai early in the year, by increased permanent staff levels, and through the employment of innovative technical solutions.

"Process improvements and investments in staffing have brought the appointment wait time for visitor visas down from an average of 1,000 days to only 250 days around the country. Wait times are minimal in all other categories," the statement read.

Last year, the US consular team in India issued over 140,000 student visas -- more than in any other country in the world setting a record for the third year in a row.

As of now, Mumbai, New Delhi, Hyderabad, and Chennai stand as the top four student visa processing posts in the world.

With these surging numbers, Indian students have become the largest group of international graduate students in the United States and make up more than a quarter of the over one million foreign students studying in the country.

Stating that employment visas remain a top priority, the Embassy stated that in 2024, a pilot program will allow eligible H-1B holders to renew their visas in the United States, further streamlining the process for this group.

Further, Consular Team India consolidated most petition-based visa processing in Chennai and Hyderabad to increase efficiency.

This led to the processing of over 380,000 employment visas for Indians and their family members in 2023 and allowed the US Mission to maintain a minimal appointment wait time.

The Consulate General Mumbai eliminated a queue of over 31,000 immigrant visa cases delayed by the Covid-19 pandemic.

"Those who have a pending immigrant visa petition and are ready for scheduling can now obtain an appointment within the standard, pre-pandemic appointment window," the Embassy stated.

MORE International ARTICLES

Reputation of AstraZeneca's COVID vaccine marred by missteps

Reputation of AstraZeneca's COVID vaccine marred by missteps
In Norway, a top official warned on Monday it might not be able to resume its use of the vaccine because so many people were rejecting it.

Reputation of AstraZeneca's COVID vaccine marred by missteps

EXPLAINER: Will you need a 'vaccine passport' to travel?

EXPLAINER: Will you need a 'vaccine passport' to travel?
It is not clear, however, whether any of the passports under development will be accepted broadly around the world, and the result could be confusion among travellers and disappointment for the travel industry.

EXPLAINER: Will you need a 'vaccine passport' to travel?

EXPLAINER: Why Georgia attack spurs fears in Asian Americans

EXPLAINER: Why Georgia attack spurs fears in Asian Americans
As details emerge, many members of the Asian American community see the Georgia killings as a haunting reminder of harassment and assaults that have been occurring from coast to coast.

EXPLAINER: Why Georgia attack spurs fears in Asian Americans

EXPLAINER: Why countries are halting the AstraZeneca shot

EXPLAINER: Why countries are halting the AstraZeneca shot
Norway, Iceland, Bulgaria, Thailand, and Congo soon followed suit. On Saturday, Norwegian authorities reported that four people under age 50 who had gotten the AstraZeneca vaccine had an unusually low number of blood platelets.

EXPLAINER: Why countries are halting the AstraZeneca shot

WHO grants emergency authorization for J&J COVID vaccine

WHO grants emergency authorization for J&J COVID vaccine
In a statement, the U.N. health agency said “the ample data from large clinical trials” shows the J&J vaccine is effective in adult populations. The emergency use listing comes a day after the European Medicines Agency recommended the shot be given the green light across the 27-country European Union.

WHO grants emergency authorization for J&J COVID vaccine

Denmark pauses AstraZeneca vaccine jabs to probe blood clots

Denmark pauses AstraZeneca vaccine jabs to probe blood clots
Denmark's Health Authority said its decision was “based on a precautionary principle” and that one person who developed a blood clot after vaccination had died.

Denmark pauses AstraZeneca vaccine jabs to probe blood clots